Project Grant HT94252510318
Award Date
4/15/25
Completion Date
4/14/29
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Alafaya, FL 32816, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,408,286.00 to the University of Texas at Dallas (UTD) to conduct a crossover randomized controlled trial on the effectiveness of an individualized progressive treatment for expanding sound tolerance in adults with autism spectrum disorder. The research aims to transform healthcare for military service members and the general public by investigating...
The Department of the Army awarded a $500,000 Project Grant under the Basic Scientific Research program (CFDA 12.431) to the University of Central Florida (UCF) on November 1, 2023. The award, titled "NEW START", will support foundational and applied research efforts over a 2-year period through October 31, 2025. As a leading research institution, UCF will leverage its extensive expertise across engineering, computer science, optics, modeling and simulation, and other disciplines to...
The Department of the Army Medical Command awarded Canisius College a $1,848,884 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a feasibility and initial efficacy study of an after-school social intervention delivered by paraprofessionals in school settings for children with autism spectrum disorder (ASD) from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program supports biomedical research to transform...
The U.S. Department of the Army Medical Command awarded a $1,229,872 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Baylor College of Medicine, a private non-profit research university, for the project "The Clinical and Genetic Architecture of Autism Spectrum Disorder among Individuals with Tuberous Sclerosis Complex". The grant, effective from July 1, 2025 to June 30, 2028, will support advanced biomedical research initiatives focused on...
This three-year Project Grant from the Defense Health Agency, totaling $847,194, will support research on "BIOMARKERS OF HYPERACUSIS IN AUTISM SPECTRUM DISORDER" at the University of Texas at Dallas from September 2023 through September 2026. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health...
The University of Central Florida Board of Trustees Office of Research, doing business as UCF, received a $499,998 Cooperative Agreement award from the U.S. Army Research, Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award will support a 2-year period of performance from January 1, 2024 to December 31, 2025. Through this funding, UCF will conduct basic and applied research across scientific and technical domains relevant to the Army,...
The University of Central Florida Board of Trustees Office of Research Division, doing business as UCF, was awarded a $799,999 Project Grant from the Office of the Secretary of Defense to support basic, applied, and advanced research in science and engineering through May 31, 2027. The award supports the Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630), which funds research and technology with potential to contribute to Department of Defense missions....
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
The University of California, Davis (UC Davis) was awarded a $321,981 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) to support research on "Sensory Processing Contributions to Emotion Dysregulation and Internalizing Problems in Autism". The grant, which runs from April 1, 2025 to March 31, 2027, will fund advanced biomedical research aimed at transforming healthcare for military service members and the...